These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
344 related items for PubMed ID: 21177196
1. [Combined detection of Epstein-Barr virus antibodies for serodiagnosis of nasopharyngeal carcinoma]. Cai YL, Zheng YM, Wang W, Wei Y, Shen XX, Cheng JR, Wu YS, Gao JQ, Zhong WM, Li J. Nan Fang Yi Ke Da Xue Xue Bao; 2010 Dec; 30(12):2746-8. PubMed ID: 21177196 [Abstract] [Full Text] [Related]
5. [Assessment of detection assays of Epstein-Barr viral Rta-IgG, VCA-IgA, EA-IgA and Epstein-Barr viral DNA at different clinical stages in the diagnosis of nasopharyngeal carcinoma]. Luo YL, Chen H, Peng SG, Lin JH, Huang PY. Zhonghua Yi Xue Za Zhi; 2013 Nov 26; 93(44):3516-9. PubMed ID: 24521892 [Abstract] [Full Text] [Related]
6. Establishment of VCA and EBNA1 IgA-based combination by enzyme-linked immunosorbent assay as preferred screening method for nasopharyngeal carcinoma: a two-stage design with a preliminary performance study and a mass screening in southern China. Liu Y, Huang Q, Liu W, Liu Q, Jia W, Chang E, Chen F, Liu Z, Guo X, Mo H, Chen J, Rao D, Ye W, Cao S, Hong M. Int J Cancer; 2012 Jul 15; 131(2):406-16. PubMed ID: 21866545 [Abstract] [Full Text] [Related]
7. [Relationship between clinical stages of nasopharyngeal carcinoma and Epstein-Barr virus antibodies Rta/IgG, EBNA1/IgA, VCA/IgA and EA/IgA]. Cai YL, Zheng YM, Cheng JR, Wang W, Zhang YN, Wang WH, Wu YS, Zhong WM, Li J, Mo YK. Nan Fang Yi Ke Da Xue Xue Bao; 2010 Mar 15; 30(3):509-11. PubMed ID: 20335122 [Abstract] [Full Text] [Related]
8. Single-assay combination of Epstein-Barr Virus (EBV) EBNA1- and viral capsid antigen-p18-derived synthetic peptides for measuring anti-EBV immunoglobulin G (IgG) and IgA antibody levels in sera from nasopharyngeal carcinoma patients: options for field screening. Fachiroh J, Paramita DK, Hariwiyanto B, Harijadi A, Dahlia HL, Indrasari SR, Kusumo H, Zeng YS, Schouten T, Mubarika S, Middeldorp JM. J Clin Microbiol; 2006 Apr 15; 44(4):1459-67. PubMed ID: 16597877 [Abstract] [Full Text] [Related]
9. Comparison of Epstein-Barr Virus Serological Tools for the Screening and Risk Assessment of Nasopharyngeal Carcinoma: a Large Population-based Study. Guo J, Cui Z, Zheng Y, Li X, Chen Y. Pathol Oncol Res; 2020 Oct 15; 26(4):2185-2190. PubMed ID: 32222897 [Abstract] [Full Text] [Related]
10. The serological diagnostic value of EBV-related IgA antibody panels for nasopharyngeal carcinoma: a diagnostic test accuracy meta-analysis. Liu H, Lei L, Song S, Geng X, Lin K, Li N, Chen W, Peng J, Ren J. BMC Cancer; 2024 Sep 07; 24(1):1115. PubMed ID: 39244576 [Abstract] [Full Text] [Related]
11. Evaluation of a semi-quantitative ELISA for IgA antibody against Epstein-Barr virus capsid antigen in the serological diagnosis of nasopharyngeal carcinoma. Chen H, Chi P, Wang W, Li L, Luo Y, Fu J, Zhang L, Liu W. Int J Infect Dis; 2014 Aug 07; 25():110-5. PubMed ID: 24878579 [Abstract] [Full Text] [Related]
12. Rta-IgG as a biomarker for diagnosis and post treatment prognostic of nasopharyngeal carcinoma. Xu XF, Lu RQ, Xiao R, Zhou L, Zhao XM, Hu XC, Gao X, Guo L. Cancer Biomark; 2016 Aug 07; 16(3):467-76. PubMed ID: 27062704 [Abstract] [Full Text] [Related]
13. Diagnostic Value of Serum Epstein-Barr Virus Capsid Antigen-IgA for Nasopharyngeal Carcinoma: a Meta-Analysis Based on 21 Studies. Chen Y, Xin X, Cui Z, Zheng Y, Guo J, Chen Y, Lin Y, Su G. Clin Lab; 2016 Aug 07; 62(6):1155-66. PubMed ID: 27468579 [Abstract] [Full Text] [Related]
14. Application of logistic regression in combination with multiple diagnostic tests for auxiliary diagnosis of nasopharyngeal carcinoma. Jiang SQ, Liu Q. Ai Zheng; 2009 Feb 07; 28(2):177-80. PubMed ID: 19550133 [Abstract] [Full Text] [Related]
15. Significance of plasma IgA and IgG antibodies to Epstein-Barr virus early and viral capsid antigens in Thai nasopharyngeal carcinoma. Tiwawech D, Srivatanakul P, Karaluk A, Ishida T. Asian Pac J Cancer Prev; 2003 Feb 07; 4(2):113-8. PubMed ID: 12875623 [Abstract] [Full Text] [Related]
16. Enhancing the efficiency of Epstein-Barr viral serologic test in the diagnosis of nasopharyngeal carcinoma. Zhang C, Zong Y, Huang B, Sun Y, Ye Y, Feng K, Li J, Zhang F. Zhonghua Zhong Liu Za Zhi; 2002 Jul 07; 24(4):356-9. PubMed ID: 12408763 [Abstract] [Full Text] [Related]
17. Expression of Epstein-Barr virus antibodies EA-IgG, Rta-IgG, and VCA-IgA in nasopharyngeal carcinoma and their use in a combined diagnostic assay. Li Y, Wang K, Yin SK, Zheng HL, Min DL. Genet Mol Res; 2016 Mar 18; 15(1):. PubMed ID: 27050964 [Abstract] [Full Text] [Related]
18. Combination of Epstein-Barr virus scaffold (BdRF1/VCA-p40) and small capsid protein (BFRF3/VCA-p18) into a single molecule for improved serodiagnosis of acute and malignant EBV-driven disease. Fachiroh J, Stevens SJ, Haryana SM, Middeldorp JM. J Virol Methods; 2010 Oct 18; 169(1):79-86. PubMed ID: 20621126 [Abstract] [Full Text] [Related]
19. Chemokine CCL27 is a novel plasma biomarker for identification the nasopharyngeal carcinoma patients from the Epstein-Barr virus capsid antigen-specific IgA seropositive population. Mao MJ, Xue N, Wang XP, Chi PD, Liu YJ, Huang Q, Dai SQ, Liu WL. BMC Cancer; 2018 Jan 02; 18(1):9. PubMed ID: 29295705 [Abstract] [Full Text] [Related]
20. [Prognostic significance of serum anti-Epstein-Barr virus antibodies in nasopharyngeal carcinoma]. Cai YL, Li J, Lu AY, Zhong WM, Zheng YM, Gao JQ, Zeng H, Chen WS, Liang W, Tang MZ. Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2013 Apr 02; 27(2):119-22. PubMed ID: 24044217 [Abstract] [Full Text] [Related] Page: [Next] [New Search]